A detailed history of West Financial Advisors, LLC transactions in Amgen Inc stock. As of the latest transaction made, West Financial Advisors, LLC holds 764 shares of AMGN stock, worth $244,907. This represents 0.05% of its overall portfolio holdings.

Number of Shares
764
Previous 764 -0.0%
Holding current value
$244,907
Previous $217,000 9.68%
% of portfolio
0.05%
Previous 0.05%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 11, 2024

SELL
$268.87 - $324.56 $83,349 - $100,613
-310 Reduced 28.86%
764 $217,000
Q4 2023

Jan 11, 2024

SELL
$255.7 - $288.46 $6,903 - $7,788
-27 Reduced 2.45%
1,074 $309,000
Q3 2023

Oct 10, 2023

BUY
$218.65 - $271.46 $5,903 - $7,329
27 Added 2.51%
1,101 $295,000
Q4 2022

Jan 10, 2023

SELL
$229.03 - $291.01 $108,789 - $138,229
-475 Reduced 30.66%
1,074 $0
Q4 2021

Jan 19, 2022

BUY
$198.88 - $227.6 $308,065 - $352,552
1,549 New
1,549 $348,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $171B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track West Financial Advisors, LLC Portfolio

Follow West Financial Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of West Financial Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on West Financial Advisors, LLC with notifications on news.